Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization.
暂无分享,去创建一个
[1] R. Chance,et al. Research, Development, Production, and Safety of Biosynthetic Human Insulin , 1993, Diabetes Care.
[2] Alain Balland,et al. Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions. , 2008, Journal of chromatography. A.
[3] A. Meager,et al. Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography method. , 2013, Journal of pharmaceutical and biomedical analysis.
[4] Damian J. Houde,et al. Conformational analysis of recombinant monoclonal antibodies with hydrogen/deuterium exchange mass spectrometry. , 2013, Methods in molecular biology.
[5] Pauline M Rudd,et al. An automated robotic platform for rapid profiling oligosaccharide analysis of monoclonal antibodies directly from cell culture. , 2013, Analytical biochemistry.
[6] S. Rudaz,et al. Analysis of recombinant monoclonal antibodies by RPLC: toward a generic method development approach. , 2012, Journal of pharmaceutical and biomedical analysis.
[7] Hongwei Xie,et al. Characterization of glycoprotein digests with hydrophilic interaction chromatography and mass spectrometry. , 2011, Analytical biochemistry.
[8] Margaret Ricci,et al. The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations. , 2007, Journal of pharmaceutical sciences.
[9] Quynh-Thu Le,et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. , 2008, The New England journal of medicine.
[10] P. Rudd,et al. Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[11] P. Carter,et al. Introduction to current and future protein therapeutics: a protein engineering perspective. , 2011, Experimental cell research.
[12] M. Tarlov,et al. Electrospray-differential mobility analysis as an orthogonal tool to size-exclusion chromatography for characterization of protein aggregates. , 2012, Journal of pharmaceutical sciences.
[13] B. Karger,et al. Analysis of isoaspartic Acid by selective proteolysis with Asp-N and electron transfer dissociation mass spectrometry. , 2010, Analytical chemistry.
[14] V. Katta,et al. Detecting low level sequence variants in recombinant monoclonal antibodies , 2010, mAbs.
[15] Vasco Filipe,et al. Mass Spectrometric Analysis of Intact Human Monoclonal Antibody Aggregates Fractionated by Size-Exclusion Chromatography , 2010, Pharmaceutical Research.
[16] Bettina Warscheid,et al. Top-down de Novo protein sequencing of a 13.6 kDa camelid single heavy chain antibody by matrix-assisted laser desorption ionization-time-of-flight/time-of-flight mass spectrometry. , 2010, Analytical chemistry.
[17] John F. Valliere-Douglass,et al. Molecular mass analysis of antibodies by on-line SEC-MS , 2008, Journal of the American Society for Mass Spectrometry.
[18] W. Jelkmann. Recombinant EPO production--points the nephrologist should know. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] S. Berkowitz,et al. Characterization of IgG1 conformation and conformational dynamics by hydrogen/deuterium exchange mass spectrometry. , 2009, Analytical chemistry.
[20] Saurabh Aggarwal,et al. What's fueling the biotech engine—2007 , 2008, Nature Biotechnology.
[21] Hendrik Neubert,et al. Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor. , 2013, Analytical chemistry.
[22] B. Yan,et al. Analysis of post-translational modifications in recombinant monoclonal antibody IgG1 by reversed-phase liquid chromatography/mass spectrometry. , 2007, Journal of chromatography. A.
[23] Alain Van Dorsselaer,et al. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[24] Y. Lou,et al. Development of capillary size exclusion chromatography for the analysis of monoclonal antibody fragments extracted from human vitreous humor. , 2012, Journal of chromatography. A.
[25] Yehia Mechref,et al. Comprehensive assessment of N‐glycans derived from a murine monoclonal antibody: A case for multimethodological approach , 2005, Electrophoresis.
[26] Gary Walsh,et al. Biopharmaceutical benchmarks 2006 , 2006, Nature Biotechnology.
[27] Difei Qiu,et al. C‐terminal lysine variants in fully human monoclonal antibodies: Investigation of test methods and possible causes , 2008, Biotechnology and bioengineering.
[28] C. F. van der Walle,et al. Therapeutic antibodies: market considerations, disease targets and bioprocessing. , 2013, International journal of pharmaceutics.
[29] M. Macht. Top-down characterization of biopharmaceuticals , 2013 .
[30] B. Karger,et al. 2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange fractionation and hydrophilic interaction UPLC reveals long poly-N-acetyl lactosamine extensions. , 2011, Analytical chemistry.
[31] S. Alley,et al. Analytical and bioanalytical technologies for characterizing antibody-drug conjugates. , 2013, Current opinion in chemical biology.
[32] J. Hubbuch,et al. A sub-two minutes method for monoclonal antibody-aggregate quantification using parallel interlaced size exclusion high performance liquid chromatography. , 2011, Journal of chromatography. A.
[33] Saurabh Aggarwal,et al. What's fueling the biotech engine? , 2007, Nature Biotechnology.
[34] Qiang Qin,et al. High-throughput immunoglobulin G N-glycan characterization using rapid resolution reverse-phase chromatography tandem mass spectrometry. , 2009, Analytical biochemistry.
[35] H. Dewald,et al. Electrochemistry-assisted top-down characterization of disulfide-containing proteins. , 2012, Analytical chemistry.
[36] P. V. van Berkel,et al. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose , 2011, Biotechnology and bioengineering.
[37] A. Raghani,et al. Analysis of monoclonal antibody product heterogeneity resulting from alternate cleavage sites of signal peptide. , 2010, Analytical biochemistry.
[38] W. Sly,et al. Identification of N-glycans displaying mannose-6-phosphate and their site of attachment on therapeutic enzymes for lysosomal storage disorder treatment. , 2011, Analytical chemistry.
[39] C. Damen,et al. Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab , 2009, Journal of the American Society for Mass Spectrometry.
[40] Saurabh Aggarwal,et al. What's fueling the biotech engine--2010 to 2011. , 2011, Nature biotechnology.
[41] R. F. Latypov,et al. Nondenaturing size-exclusion chromatography-mass spectrometry to measure stress-induced aggregation in a complex mixture of monoclonal antibodies. , 2013, Analytical chemistry.
[42] W. Hancock,et al. Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation. , 2011, Analytical chemistry.
[43] T. Dierks,et al. Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] K. Sandra,et al. Highly efficient peptide separations in proteomics. Part 2: bi- and multidimensional liquid-based separation techniques. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[45] Wolfgang Lindner,et al. Comparison of hydrophilic-interaction, reversed-phase and porous graphitic carbon chromatography for glycan analysis. , 2011, Journal of chromatography. A.
[46] P. Caliceti,et al. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[47] W. Xu,et al. Determination of deamidation artifacts introduced by sample preparation using 18O-labeling and tandem mass spectrometry analysis. , 2012, Analytical chemistry.
[48] J. R. Engen,et al. Hydrogen exchange mass spectrometry: what is it and what can it tell us? , 2010, Analytical and bioanalytical chemistry.
[49] W. Hancock,et al. Identification of the unpaired cysteine status and complete mapping of the 17 disulfides of recombinant tissue plasminogen activator using LC-MS with electron transfer dissociation/collision induced dissociation. , 2010, Analytical Chemistry.
[50] Aditya A Wakankar,et al. Analytical methods for physicochemical characterization of antibody drug conjugates , 2011, mAbs.
[51] Saurabh Aggarwal,et al. What's fueling the biotech engine—2011 to 2012 , 2012, Nature Biotechnology.
[52] André M Deelder,et al. Oligosaccharide analysis by graphitized carbon liquid chromatography–mass spectrometry , 2009, Analytical and bioanalytical chemistry.
[53] R. F. Latypov,et al. Characterization of a unique IgG1 mAb CEX profile by limited Lys-C proteolysis/CEX separation coupled with mass spectrometry and structural analysis. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[54] D. Chelius,et al. 18O labeling method for identification and quantification of succinimide in proteins. , 2007, Analytical chemistry.
[55] Zheng Ouyang,et al. A universal surrogate peptide to enable LC-MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in pre-clinical animal studies. , 2012, Biomedical chromatography : BMC.
[56] Z. Li,et al. Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.
[57] R. Dwek,et al. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. , 1996, Analytical biochemistry.
[58] Yehia Mechref,et al. Use of CID/ETD Mass Spectrometry to Analyze Glycopeptides , 2012, Current protocols in protein science.
[59] Pauline M. Rudd,et al. GlycoBase and autoGU: tools for HPLC-based glycan analysis , 2008, Bioinform..
[60] Saurabh Aggarwal,et al. What's fueling the biotech engine—2009–2010 , 2010, Nature Biotechnology.
[61] Gregory C Flynn,et al. Analysis of N-glycans from recombinant immunoglobulin G by on-line reversed-phase high-performance liquid chromatography/mass spectrometry. , 2007, Analytical biochemistry.
[62] M. Karas,et al. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.
[63] R J Harris,et al. Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture. , 1995, Journal of chromatography. A.
[64] M. C. García,et al. The effect of the mobile phase additives on sensitivity in the analysis of peptides and proteins by high-performance liquid chromatography-electrospray mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[65] John F. Valliere-Douglass,et al. Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues. , 2012, Analytical chemistry.
[66] David B Volkin,et al. Analytical lessons learned from selected therapeutic protein drug comparability studies. , 2013, Biologicals : journal of the International Association of Biological Standardization.
[67] M. Mann,et al. Electrospray ionization for mass spectrometry of large biomolecules. , 1989, Science.
[68] D. Guillarme,et al. Critical evaluation of fast size exclusion chromatographic separations of protein aggregates, applying sub-2 μm particles. , 2013, Journal of pharmaceutical and biomedical analysis.
[69] T. Patapoff,et al. Improving pH gradient cation-exchange chromatography of monoclonal antibodies by controlling ionic strength. , 2013, Journal of chromatography. A.
[70] Y. Mechref,et al. Glycomic analysis by capillary electrophoresis-mass spectrometry. , 2009, Mass spectrometry reviews.
[71] D. Chelius,et al. Reversed-phase liquid chromatography in-line with negative ionization electrospray mass spectrometry for the characterization of the disulfide-linkages of an immunoglobulin gamma antibody , 2006, Journal of the American Society for Mass Spectrometry.
[72] Yehia Mechref,et al. Enzymatic/chemical release of O-glycans allowing MS analysis at high sensitivity. , 2009, Analytical chemistry.
[73] Lihua Huang,et al. Epitope mapping of antibodies by mass spectroscopy: a case study. , 2013, Methods in molecular biology.
[74] Mingxiang Li,et al. Separation of oxidized variants of a monoclonal antibody by anion-exchange. , 2011, Journal of chromatography. A.
[75] Damon L. Meyer,et al. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. , 2003, Blood.
[76] Gary Walsh,et al. Biopharmaceutical benchmarks 2010 , 2010, Nature Biotechnology.
[77] F. Sörgel,et al. Reversed-phase liquid-chromatographic mass spectrometric N-glycan analysis of biopharmaceuticals , 2013, Analytical and Bioanalytical Chemistry.
[78] S. Sanglier-Cianférani,et al. Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS. , 2009, Analytical chemistry.
[79] Jingming Zhang,et al. Conformational characterization of the charge variants of a human IgG1 monoclonal antibody using H/D exchange mass spectrometry , 2013, mAbs.
[80] A. Lim,et al. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. , 2007, Mass spectrometry reviews.
[81] Reed J. Harris,et al. Non-enzymatic hinge region fragmentation of antibodies in solution. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[82] Alain Van Dorsselaer,et al. Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.
[83] M F Bean,et al. Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of glycopeptides in protein digests. , 1993, Analytical chemistry.
[84] Sheng Yin,et al. Development of a native nanoelectrospray mass spectrometry method for determination of the drug-to-antibody ratio of antibody-drug conjugates. , 2013, Analytical chemistry.
[85] Gary Walsh,et al. Post-translational modifications of protein biopharmaceuticals. , 2009, Drug discovery today.
[86] Analytical characterization of a novel degradation product in a PEGylated recombinant protein. , 2011, Journal of pharmaceutical sciences.
[87] Y. Yu,et al. Using Hydrogen/Deuterium Exchange Mass Spectrometry to Study Conformational Changes in Granulocyte Colony Stimulating Factor upon PEGylation , 2012, Journal of The American Society for Mass Spectrometry.
[88] Alain Van Dorsselaer,et al. Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. , 2012, Analytical chemistry.
[89] Lawrence W. Dick,et al. Peptide mapping of therapeutic monoclonal antibodies: improvements for increased speed and fewer artifacts. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[90] D. Guillarme,et al. Kinetic evaluation of new generation of column packed with 1.3 μm core-shell particles. , 2013, Journal of chromatography. A.
[91] S. Berkowitz,et al. The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies. , 2011, Journal of pharmaceutical sciences.
[92] Guodong Chen,et al. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies , 2011, Analytical and Bioanalytical Chemistry.
[93] M. O'Callaghan,et al. Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease. , 2008, Molecular genetics and metabolism.
[94] Zhongqi Zhang,et al. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry. , 2007, Analytical chemistry.
[95] Y. Mechref,et al. Resolving and assigning N-linked glycan structural isomers from ovalbumin by IMS-MS , 2008, Journal of the American Society for Mass Spectrometry.
[96] E. Ezan,et al. Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum. , 2008, Analytical chemistry.
[97] J. Veuthey,et al. New trends in reversed-phase liquid chromatographic separations of therapeutic peptides and proteins: theory and applications. , 2012, Journal of pharmaceutical and biomedical analysis.
[98] Surinder Kaur,et al. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry. , 2011, Analytical biochemistry.
[99] Ruedi Aebersold,et al. The Implications of Proteolytic Background for Shotgun Proteomics*S , 2007, Molecular & Cellular Proteomics.
[100] Ingo H Gorr,et al. Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach , 2012, PloS one.
[101] Martin Schiestl,et al. Acceptable changes in quality attributes of glycosylated biopharmaceuticals , 2011, Nature Biotechnology.
[102] J. Gebler,et al. Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry. , 2009, Analytical chemistry.
[103] M. F. Bean,et al. Selective identification and differentiation of N‐and O‐linked oligosaccharides in glycoproteins by liquid chromatography‐mass spectrometry , 1993, Protein science : a publication of the Protein Society.
[104] Hossein Salimi-Moosavi,et al. General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies. , 2012, Analytical chemistry.
[105] Wei Zhang,et al. Complete disulfide bond assignment of a recombinant immunoglobulin G4 monoclonal antibody. , 2002, Analytical biochemistry.
[106] Natalie J. Thompson,et al. Tackling the increasing complexity of therapeutic monoclonal antibodies with mass spectrometry , 2013 .
[107] André M Deelder,et al. Glycoproteomics based on tandem mass spectrometry of glycopeptides. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[108] William S. Hancock,et al. Development of different analysis platforms with LC-MS for pharmacokinetic studies of protein drugs. , 2009, Analytical chemistry.
[109] S. Clarke,et al. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. , 1987, The Journal of biological chemistry.
[110] Serge Rudaz,et al. Intact protein analysis in the biopharmaceutical field. , 2011, Journal of pharmaceutical and biomedical analysis.
[111] Cheng Lin,et al. Detecting deamidation products in proteins by electron capture dissociation. , 2006, Analytical chemistry.
[112] Pat Sandra,et al. Comprehensive liquid chromatography: fundamental aspects and practical considerations--a review. , 2009, Analytica chimica acta.
[113] C. Beddell,et al. Mass spectrometry of the humanized monoclonal antibody CAMPATH 1H. , 1995, Analytical chemistry.
[114] R. Gurny,et al. New methods allowing the detection of protein aggregates , 2009, mAbs.
[115] P. Schnier,et al. Resolving disulfide structural isoforms of IgG2 monoclonal antibodies by ion mobility mass spectrometry. , 2010, Analytical chemistry.
[116] Y. Lou,et al. Validation of a pH gradient-based ion-exchange chromatography method for high-resolution monoclonal antibody charge variant separations. , 2011, Journal of pharmaceutical and biomedical analysis.
[117] Hendrik Neubert,et al. Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MS. , 2012, Analytical chemistry.
[118] C. Scarff,et al. MALDI-MS/MS with Traveling Wave Ion Mobility for the Structural Analysis of N-Linked Glycans , 2012, Journal of The American Society for Mass Spectrometry.
[119] Ya-jun Guo,et al. Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products , 2012, mAbs.
[120] D. Harvey. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008. , 2012, Mass spectrometry reviews.
[121] Eric Ezan,et al. Critical comparison of MS and immunoassays for the bioanalysis of therapeutic antibodies. , 2009, Bioanalysis.
[122] Hongwei Xie,et al. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies , 2010, mAbs.
[123] Olivier Heudi,et al. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry. , 2008, Analytical chemistry.
[124] Igor A Kaltashov,et al. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. , 2012, Biotechnology advances.
[125] Milos V. Novotny,et al. High-sensitivity analytical approaches for the structural characterization of glycoproteins. , 2013, Chemical reviews.
[126] Damian Houde,et al. Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding* , 2010, Molecular & Cellular Proteomics.
[127] I. Kaltashov,et al. Impact of oxidation on protein therapeutics: Conformational dynamics of intact and oxidized acid‐β‐glucocerebrosidase at near‐physiological pH , 2010, Protein science : a publication of the Protein Society.
[128] Renate Kunert,et al. Analysis of immunoglobulin glycosylation by LC‐ESI‐MS of glycopeptides and oligosaccharides , 2008, Proteomics.
[129] J. Reichert. Which are the antibodies to watch in 2012? , 2012, mAbs.
[130] John R. Engen,et al. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars , 2012, Nature Reviews Drug Discovery.
[131] Natalie J. Thompson,et al. Qualitative and semiquantitative analysis of composite mixtures of antibodies by native mass spectrometry. , 2012, Analytical chemistry.
[132] M. Sliwkowski,et al. Trastuzumab Emtansine: A Unique Antibody-Drug Conjugate in Development for Human Epidermal Growth Factor Receptor 2–Positive Cancer , 2011, Clinical Cancer Research.
[133] Erinc Sahin,et al. Size-exclusion chromatography with multi-angle light scattering for elucidating protein aggregation mechanisms. , 2012, Methods in molecular biology.
[134] B. Kabakoff,et al. Identification of multiple sources of charge heterogeneity in a recombinant antibody. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[135] M. Gerhart,et al. Characterization of a novel modification on IgG2 light chain. Evidence for the presence of O-linked mannosylation. , 2007, Journal of chromatography. A.
[136] Scott A. McLuckey,et al. Differentiation of aspartic and isoaspartic acids using electron transfer dissociation , 2006, Journal of the American Society for Mass Spectrometry.
[137] N. Bihoreau,et al. Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry. , 2011, Analytical biochemistry.
[138] Elevated temperature-extended column length conventional liquid chromatography to increase peak capacity for the analysis of tryptic digests. , 2007, Journal of separation science.
[139] P. Bondarenko,et al. Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs , 2008, Journal of the American Society for Mass Spectrometry.
[140] P. Schnier,et al. Gas-phase proton-transfer chemistry coupled with TOF mass spectrometry and ion mobility-MS for the facile analysis of poly(ethylene glycols) and PEGylated polypeptide conjugates. , 2008, Analytical chemistry.
[141] W. Xu,et al. Disulfide bond assignment of an IgG1 monoclonal antibody by LC-MS with post-column partial reduction. , 2013, Analytical biochemistry.
[142] J. Rohrer,et al. Protein variant separations using cation exchange chromatography on grafted, polymeric stationary phases , 2001, Proteomics.
[143] I. Apostol,et al. Incorporation of Norvaline at Leucine Positions in Recombinant Human Hemoglobin Expressed in Escherichia coli* , 1997, The Journal of Biological Chemistry.
[144] D. Farnan,et al. Multiproduct high-resolution monoclonal antibody charge variant separations by pH gradient ion-exchange chromatography. , 2009, Analytical chemistry.
[145] Janice M. Reichert,et al. Marketed therapeutic antibodies compendium , 2012, mAbs.
[146] K. Ganzler,et al. Analytical aspects of biosimilarity issues of protein drugs. , 2012, Journal of pharmaceutical and biomedical analysis.
[147] J. Zhu-Shimoni,et al. Identification of a single base-pair mutation of TAA (Stop codon) → GAA (Glu) that causes light chain extension in a CHO cell derived IgG1 , 2012, mAbs.
[148] S. Tuske,et al. Mapping of discontinuous conformational epitopes by amide hydrogen/deuterium exchange mass spectrometry and computational docking , 2012, Journal of molecular recognition : JMR.
[149] W. Alley,et al. Characterization of glycopeptides by combining collision-induced dissociation and electron-transfer dissociation mass spectrometry data. , 2009, Rapid communications in mass spectrometry : RCM.
[150] Weibin Chen,et al. Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.
[151] François Debaene,et al. Analytical characterization of biosimilar antibodies and Fc-fusion proteins , 2013 .
[152] Serge Rudaz,et al. Analytical strategies for the characterization of therapeutic monoclonal antibodies , 2013 .
[153] K. Pagel,et al. Ion mobility-mass spectrometry of complex carbohydrates: collision cross sections of sodiated N-linked glycans. , 2013, Analytical chemistry.
[154] D. Ejima,et al. The critical role of mobile phase composition in size exclusion chromatography of protein pharmaceuticals. , 2010, Journal of pharmaceutical sciences.
[155] Shu-Hui Chen,et al. A global comparability approach for biosimilar monoclonal antibodies using LC-tandem MS based proteomics. , 2013, Journal of pharmaceutical and biomedical analysis.
[156] François Debaene,et al. Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation. , 2013, Analytical chemistry.
[157] A. Marshall,et al. Top-down structural analysis of an intact monoclonal antibody by electron capture dissociation-Fourier transform ion cyclotron resonance-mass spectrometry. , 2013, Analytical chemistry.
[158] W. Hancock,et al. Mass spectrometric determination of disulfide linkages in recombinant therapeutic proteins using online LC-MS with electron-transfer dissociation. , 2009, Analytical chemistry.
[159] C. Fritsch,et al. Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab , 2013, BioDrugs.
[160] P. Bondarenko,et al. Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-orbitrap mass spectrometer , 2009, Journal of the American Society for Mass Spectrometry.
[161] G. Guiochon,et al. Mass transfer kinetics, band broadening and column efficiency. , 2012, Journal of chromatography. A.
[162] Milos V Novotny,et al. Recent trends in analytical and structural glycobiology. , 2013, Current opinion in chemical biology.
[163] B. Warrack,et al. Characterization of protein therapeutics by mass spectrometry: recent developments and future directions. , 2011, Drug discovery today.
[164] Min-Yuan Chou,et al. Automatic disulfide bond assignment using a1 ion screening by mass spectrometry for structural characterization of protein pharmaceuticals. , 2012, Analytical chemistry.
[165] L. Ilag,et al. Discrimination among IgG1-κ monoclonal antibodies produced by two cell lines using charge state distributions in nanoESI-TOF mass spectra , 2009, Journal of the American Society for Mass Spectrometry.
[166] S. Burman,et al. Facile method of quantification for oxidized tryptophan degradants of monoclonal antibody by mixed mode ultra performance liquid chromatography. , 2012, Journal of chromatography. A.
[167] Hongcheng Liu,et al. Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry , 2009, Journal of the American Society for Mass Spectrometry.
[168] Gang Xiao,et al. Identification and quantification of degradations in the Asp-Asp motifs of a recombinant monoclonal antibody. , 2008, Journal of pharmaceutical and biomedical analysis.
[169] Zhongqi Zhang,et al. Mass spectrometry for structural characterization of therapeutic antibodies. , 2009, Mass spectrometry reviews.
[170] N. Avdalović,et al. Analysis of carbohydrates on IgG preparations. , 1994, Journal of pharmaceutical sciences.
[171] D. Frey,et al. Monoclonal antibody heterogeneity analysis and deamidation monitoring with high-performance cation-exchange chromatofocusing using simple, two component buffer systems. , 2013, Journal of chromatography. A.
[172] K. Sandra,et al. Highly efficient peptide separations in proteomics Part 1. Unidimensional high performance liquid chromatography. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[173] Li Yang,et al. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. , 2007, Analytical biochemistry.
[174] Xinping Fang,et al. LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup. , 2007, Analytical chemistry.
[175] Rahul S Rajan,et al. Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. , 2006, Analytical chemistry.
[176] A. Nava,et al. Capillary size exclusion chromatography with picogram sensitivity for analysis of monoclonal antibodies purified from harvested cell culture fluid. , 2012, Journal of chromatography. A.
[177] W. Hancock,et al. Characterization of the glycosylation occupancy and the active site in the follow-on protein therapeutic: TNK-tissue plasminogen activator. , 2010, Analytical chemistry.
[178] Albert J R Heck,et al. Performing native mass spectrometry analysis on therapeutic antibodies. , 2014, Methods.
[179] Y. Kao,et al. On-line characterization of monoclonal antibody variants by liquid chromatography-mass spectrometry operating in a two-dimensional format. , 2011, Analytical biochemistry.
[180] Alain Balland,et al. Characterization of nonenzymatic glycation on a monoclonal antibody. , 2007, Analytical chemistry.
[181] T. Hayakawa,et al. Selective glycopeptide mapping of erythropoietin by on-line high-performance liquid chromatography--electrospray ionization mass spectrometry. , 2001, Journal of chromatography. A.
[182] J. V. Van Beeumen,et al. Characterization of cellobiohydrolase I N-glycans and differentiation of their phosphorylated isomers by capillary electrophoresis-Q-Trap mass spectrometry. , 2004, Analytical chemistry.
[183] F. Wurm,et al. Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry. , 2011, Analytical chemistry.
[184] André M Deelder,et al. IgG glycosylation analysis , 2009, Proteomics.
[185] B. Yan,et al. HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[186] M. Fountoulakis,et al. Effect of the hydrolysis method on the determination of the amino acid composition of proteins. , 1998, Journal of chromatography. A.
[187] Jason C Rouse,et al. Unit mass baseline resolution for an intact 148 kDa therapeutic monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometry. , 2011, Analytical chemistry.
[188] Bruce A Kerwin,et al. Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody. , 2011, Journal of pharmaceutical sciences.
[189] Qian Wang,et al. On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product. , 2012, Journal of chromatography. A.
[190] R. Ionescu,et al. Fragmentation of monoclonal antibodies , 2011, mAbs.
[191] C. Eng,et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) , 2006, Genetics in Medicine.
[192] Koichi Tanaka,et al. Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry , 1988 .
[193] R. O'neill. Enzymatic release of oligosaccharides from glycoproteins for chromatographic and electrophoretic analysis. , 1996, Journal of chromatography. A.
[194] J. Yoo,et al. Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS. , 2013, Bioanalysis.
[195] Simona Jevševar,et al. PEGylation of therapeutic proteins , 2010, Biotechnology journal.
[196] Darrell Ricke,et al. Absolute quantification of monoclonal antibodies in biofluids by liquid chromatography-tandem mass spectrometry. , 2008, Analytical chemistry.
[197] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[198] Da Ren,et al. Elucidation of Degradants in Acidic Peak of Cation Exchange Chromatography in an IgG1 Monoclonal Antibody Formed on Long-Term Storage in a Liquid Formulation , 2011, Pharmaceutical Research.
[199] Pauline M Rudd,et al. Automated, high-throughput IgG-antibody glycoprofiling platform. , 2013, Analytical chemistry.
[200] Max Tejada,et al. Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody. , 2012, Analytical chemistry.
[201] Wolfgang Lindner,et al. HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals , 2010, Analytical and bioanalytical chemistry.
[202] D. Ouellette,et al. Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule , 2013, mAbs.
[203] I. Kaltashov,et al. Advanced mass spectrometry-based methods for the analysis of conformational integrity of biopharmaceutical products. , 2011, Current pharmaceutical biotechnology.
[204] R. Ionescu,et al. Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods. , 2008, Current pharmaceutical biotechnology.
[205] S. Berkowitz,et al. Conformation and dynamics of biopharmaceuticals: Transition of mass spectrometry-based tools from academe to industry , 2010, Journal of the American Society for Mass Spectrometry.
[206] Jason C Rouse,et al. Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain. , 2007, Analytical biochemistry.
[207] E. Ezan,et al. MS-based approaches for studying the pharmacokinetics of protein drugs. , 2011, Bioanalysis.
[208] N. Leymarie,et al. Effective use of mass spectrometry for glycan and glycopeptide structural analysis. , 2012, Analytical chemistry.
[209] Neil L. Kelleher,et al. Analysis of Intact Monoclonal Antibody IgG1 by Electron Transfer Dissociation Orbitrap FTMS* , 2012, Molecular & Cellular Proteomics.
[210] Scott A McLuckey,et al. Complementary structural information from a tryptic N-linked glycopeptide via electron transfer ion/ion reactions and collision-induced dissociation. , 2005, Journal of proteome research.
[211] Rainer Bischoff,et al. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[212] Gerd R Kleemann,et al. Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability. , 2006, Journal of chromatography. A.
[213] Gang Xiao,et al. Reversed-phase liquid chromatography-mass spectrometry of site-specific chemical modifications in intact immunoglobulin molecules and their fragments. , 2008, Journal of chromatography. A.
[214] M. Doyle,et al. Structural mass spectrometry in protein therapeutics discovery. , 2010, Analytical chemistry.
[215] I. Kaltashov,et al. An 18O-labeling assisted LC/MS method for assignment of aspartyl/isoaspartyl products from Asn deamidation and Asp isomerization in proteins. , 2013, Analytical chemistry.
[216] M. Fountoulakis,et al. Hydrolysis and amino acid composition analysis of proteins , 1998 .
[217] P. Motchnik,et al. Characterization of monoclonal antibody size variants containing extra light chains , 2013, mAbs.
[218] B. Devreese,et al. The Q-trap mass spectrometer, a novel tool in the study of protein glycosylation , 2004, Journal of the American Society for Mass Spectrometry.
[219] Bettina Bardl,et al. Simultaneous analysis of the non-canonical amino acids norleucine and norvaline in biopharmaceutical-related fermentation processes by a new ultra-high performance liquid chromatography approach , 2013, Amino Acids.
[220] Simon J. Henderson,et al. Monoclonal antibody therapeutics: history and future. , 2012, Current opinion in pharmacology.
[221] R. Townsend,et al. Chromatography of carbohydrates , 1988, Nature.
[222] C. Horváth,et al. High-speed high-performance liquid chromatography of peptides and proteins. , 1995, Journal of chromatography. A.
[223] Y. Mechref. Analysis of glycans derived from glycoconjugates by capillary electrophoresis‐mass spectrometry , 2011, Electrophoresis.
[224] A. Vijaya Bhaskar Reddy,et al. A selective and sensitive UPLC-MS/MS approach for trace level quantification of four potential genotoxic impurities in zolmitriptan drug substance. , 2013, Journal of pharmaceutical and biomedical analysis.